Previous close | 0.0564 |
Open | 0.0543 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0511 - 0.0566 |
52-week range | 0.0250 - 0.1110 |
Volume | |
Avg. volume | 190,516 |
Market cap | 23.785M |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings date | 23 Mar 2023 - 27 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Equity capital to facilitate commercial scale production of CELLFTORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced that it has completed a second tranche under its previously announced draw-down equity facility with Alumina Partners (Ontario) Ltd. ("Alu
Marks major milestone toward imminent availability for sale to customersTORONTO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”) has begun commercial scale production of a new and impr
Answering Customer Demand from Retailers and Consumers, CannMart’s In-house Brand Roilty Introduces First-to-Market Multi-pack Formats Across Several Cannabis Concentrate CategoriesTORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced that its wholly owned